RT Journal Article
SR Electronic
T1 1167 Prediction of first-in-human dose for HPN536, a T-cell engager targeting mesothelin: MABEL vs mechanistic translational PK/RO/PA modeling
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1286
OP A1286
DO 10.1136/jitc-2023-SITC2023.1167
VO 11
IS Suppl 1
A1 Demin, Oleg
A1 Shchelokov, Dmitry
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1286.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.